H-1B Filings
160
Major sponsor. DOL labor condition applications on file.
AbbVie Inc. in IL (Manufacturing) is a sponsorship-and-safety profile: 160 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
AbbVie Inc. (IL): · 160 H-1B LCAs at a $156,785 disclosed median · OSHA Grade A (DART 0.07)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, AbbVie Inc. in IL carries 160 H-1B wage filings on record, a $156,785 median wage across 156 disclosed-wage positions (above the $124,488 national median), a strong A OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #286 of 51,370 sponsors in this corpus (about the 99th percentile), and disclosed median wage sits at the 73rd percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
160
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$156,785
Above national median. Across 156 disclosed positions
OSHA Safety Grade
Grade A · DART 0.07
Safer than industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where AbbVie Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$156,785 Top 27% higher than 73% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+12% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | AbbVie Inc. | DOL OFLC / OSHA |
| Industry | Manufacturing | NAICS / DOL |
| State | IL | U.S. Federal Records |
| H-1B Filings | 160 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $156,785 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.07 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
AbbVie Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in IL (Manufacturing). In this corpus, H-1B filing volume ranks #286 of 51,370 sponsors in this corpus (about the 99th percentile); disclosed median wage sits at the 73rd percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 63% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Medical Director - Oncology Treatment Exp., Insights & Ed. | $335,000 |
| Medical Director-Oncology Treatment Exp., Insights & Educ. | $335,000 |
| ASSOCIATE DIRECTOR, INTERNATIONAL COMPETITIVE INTELLIGENCE | $284,000 |
| Medical Director, Clinical Development - Oncology | $265,000 |
| DIRECTOR, CLINICAL TECHNOLOGY STRATEGY AND OPERATIONS | $250,000 |
| Senior Director, Head of mRNA Drug Substance | $241,921 |
| Director, Data, Digital and Technology Lead | $240,399 |
| DIRECTOR I, CLINICAL INNOVATION, STRATEGY | $240,000 |
| SCIENTIFIC DIRECTOR, MHI | $233,000 |
| DIRECTOR, BTS | $229,000 |
| DIRECTOR, R&D INNOVATION | $221,000 |
| Director, BTS Immunology Patient Care Models | $215,000 |
| Director, RA Global Regulatory Strategy | $215,000 |
| ASSOCIATE DIRECTOR, IT | $214,000 |
| ASSOCIATE DIRECTOR, INNOVATION | $210,000 |
| DIRECTOR, CLINICAL PHARMACOLOGY | $208,000 |
| DIRECTOR, BUSINESS OPERATIONS AND STRATEGY | $205,000 |
| Director, Clinical Pharmacology | $203,350 |
| ASSOCIATE DIRECTOR, GLOBAL MARKETING - ONCOLOGY | $201,000 |
| ASSOCIATE DIRECTOR, STATISTICS | $200,000 |
| ASSOCIATE DIRECTOR, RA GLOBAL REGULATORY STRATEGY | $195,000 |
| Peptide Chemist, Principal Research Scientist I | $193,000 |
| SENIOR TECHNOLOGY MANAGER, DATA ENGINEERING | $189,000 |
| PRINCIPAL ENGINEER, TECHNOLOGY | $188,000 |
| Prin. Data Engineer, Info. Security Strategy & Intelligence | $187,280 |
| SENIOR BUSINESS SYSTEMS CONSULTANT | $187,000 |
| ASSISTANT SCIENTIFIC DIRECTOR | $186,000 |
| Associate Director,Global Procurement Process Lead | $185,817 |
| Principal Research Scientist I | $185,000 |
| SENIOR MANAGER, STATISTICAL PROGRAMMING | $185,000 |
| ENTERPRISE DATA ARCHITECT | $185,000 |
| ASSOCIATE DIRECTOR, CLINICAL DATA SYSTEMS | $185,000 |
| ARCHITECT, TECHNOLOGY II | $181,000 |
| Generative AI Architect | $180,000 |
| Sr. Technical Business Relationship Manager -Revenue Mgmt | $180,000 |
| Senior Manager, Statistics | $180,000 |
| SAP RTR Architect: Product Costing and Margin Accounting | $179,827 |
| SALESFORCE DATA AND INTEGRATION LEAD | $177,000 |
| Associate Director, HEOR Real World Evidence (RWE) | $176,375 |
| Principal Research Scientist I, tLNP Formulation | $175,000 |
| ARCHITECT, APPLICATION | $174,000 |
| ASSOCIATE DIRECTOR, HEOR - IMMUNOLOGY | $174,000 |
| SR. BUSINESS SYSTEM CONSULTANT, REPORTING AND CONSOLIDATION | $173,000 |
| SYSTEMS DESIGN ANALYST II | $173,000 |
| Principal Research Scientist | $171,064 |
| AEM Engineer | $170,000 |
| ASSOCIATE DIRECTOR, REGULATORY AFFAIRS, CMC | $170,000 |
| Sr. SAP Analytics Developer | $170,000 |
| SENIOR PROGRAM MANAGER, BTS US COMMERICAL PATIENT SERVICES | $170,000 |
| SENIOR ENGINEER, TECHNOLOGY II | $169,000 |
AbbVie Inc.'s most extreme placement is sponsorship scale: 160 H-1B LCAs rank higher than 99% of sponsors in this corpus (#286 of 51,370).
OSHA logged 114 injuries at a DART rate of 0.1 against a 1.1 same-NAICS-sector average (Grade A).
No WARN Act mass-layoff notices are on file for AbbVie Inc. among Manufacturing employers we track.
Disclosed pay runs high: $156,785 median beats 73% of credible wage rows and sits above the $124,488 national median.
FY2025 added 12 filings versus FY2024 (30.8%), a sponsorship expansion visible in the raw LCA counts.
Disclosed medians moved from $144,441 (FY2024) to $161,722 (FY2025) (+12%), weighted by this employer's own LCA rows — not a company-wide raise and not role-mix adjusted.
AbbVie Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 114.
Where AbbVie Inc. sits
Across the 200 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, AbbVie Inc. files more petitions than 88% of them and discloses a higher median wage than 72%, the high-volume, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (160 filings · $156,785 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 40; the brand marker is AbbVie Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
AbbVie Inc.'s nearest H-1B-filing peers in Manufacturing (home state IL). Each card links to that employer's federal-records profile.
Two federal-records peer sets for AbbVie Inc., both outside IL so the neighborhoods are not the same-industry VsCard above.
Nearest nationwide sponsors outside IL (160 filings here).
Nearest injury-rate peers outside IL (DART 0.07 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
What to check before working with AbbVie Inc.
For AbbVie Inc., read sponsorship pay (160 H-1B LCAs, median $156,785) next to the OSHA safety grade (A).
AbbVie Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, AbbVie Inc.'s disclosed median of $156,785 sits at the 73rd percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
AbbVie Inc. has 160 H-1B filings on record, ranking #286 of 51,370 sponsors in this corpus (about the 99th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
AbbVie Inc. carries Grade A from its establishment injury record (114 injuries on file; DART 0.07). That DART rate is safer than roughly 63% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.